• Trump To Sign Executive Order Promoting Artificial Intelligence

    The New York Times | President Trump is expected to sign an executive order meant to spur the development and regulation of AI. But the order does not set aside additional funds for AI development, and officials provided few details on how it will track the progress of its new policies.

    Feb 11, 2019

  • Clinical Genomics Insights In Hematological Malignancies Require Streamlined Bioinformatics Solutions

    Bio-IT World Contributed Commentary | Next-generation sequencing has transformed the field of oncology. Early successes in identifying and targeting oncogenic drivers of solid tumors have set the foundation for genomics-guided precision medicine; but, for hematological malignancies, the path to precision medicine is a lot more complex.

    Feb 8, 2019

  • Oxford Nanopore Launches cDNA Kits

    Bio-IT World News Brief  Oxford Nanopore has launched new ‘109’ cDNA Kits for its real-time, scalable sequencing technology.   The new kits provide high throughput while generating complete sequences of full-length cDNA strands, with a low input option of just 1 ng PolyA+ RNA.

    Feb 5, 2019

  • CRISPR's Gene Editing Toolbox Is Expanding

    Los Angeles Times | The scientists who developed the revolutionary gene-editing system known as CRISPR are improving it with new tools that make it work better.

    Feb 5, 2019

  • GA4GH Adds Seven Genomic Data Initiatives As New Driver Projects

    Bio-IT World News Brief | The Global Alliance for Genomics and Health (GA4GH) has named seven of the world’s leading genomic data initiatives as new Driver Projects for 2019.

    Feb 4, 2019

  • Collaboration And Machine Learning Key For 23andMe’s Drug Discovery Efforts

    Bio-IT World | 23andMe is at the forefront of a collaborative effort to forge partnerships with pharma companies and research institutes to improve drug discovery, as well as use resources to capitalize on the growth of personalized medicine.

    Jan 31, 2019

  • Copyright Clearance Center, PAREXEL, Eaton, And More: News From January 2019

    Bio-IT World | January featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Copyright Clearance Center, PAREXEL, Eaton, and more. 

    Jan 30, 2019

  • After “CRISPR Babies,” Medical Leaders To Tighten Genome Editing Rules

    STAT | Less than two years after the U.S. National Academy of Medicine produced an exhaustive report on human genome editing, it is planning an international commission on the most controversial use of that technology — creating “CRISPR babies.”

    Jan 24, 2019

  • Quake Lab Utilizes RNA Sequencing Tool For Food Allergy Diagnostics

    Bio-IT World | Researchers in the Stanford lab of Stephen Quake are using single cell RNA sequencing in an effort to provide insight into food allergies and the antibodies that cause them.

    Jan 24, 2019

  • Artificial Intelligence In Health Care IT – The Potential And The Watch-Outs

    Bio-IT World Contributed Commentary | Few topics have captured the imagination of the general public and executives in the healthcare IT world like Artificial Intelligence. It is important to look beyond the Sci-Fi of AI and instead look at Artificial Intelligence from a purely computer science perspective.

    Jan 21, 2019

  • Deadline For Innovative Practices Awards Entries: What You Need To Know

    Bio-IT World | There’s still time to submit an entry for the inaugural Innovative Practices Awards. But the final deadline is coming soon.

    Jan 21, 2019

  • EMERSE: How Better Big Data Search Could Change Healthcare

    Bio-IT World | The electronic health record (EHR) has become both a blessing and a curse for many people in healthcare. Software tools are now available that can help to leverage the data in these documents, one of which is EMERSE, the electronic medical record search engine.

    Jan 16, 2019

  • GenScript Launches Instrument For Protein, Antibody Purification

    Bio-IT World News Brief | GenScript today announced the AmMag SA semi-automatic purification instrument, a novel technology that accelerates and simplifies protein and antibody purification, reducing the process from days to hours.

    Jan 14, 2019

  • How Common Data Could Lead To Uncommon Alzheimer’s Discoveries

    Bio-IT World | Now that healthcare and IT are so closely intertwined, the onslaught of data presents possibilities like never before, and those caught up in the effort to save current and future generations from the ravages of Alzheimer’s disease wonder how all this data might be better used to pinpoint patterns of interest and discover pathways for treatments.

    Jan 14, 2019

  • MGI Announces First Customer For MGISEQ-T7, Complete Genomics Accuracy Tech

    Bio-IT World News Brief | At the J.P. Morgan Healthcare Conference this week, MGI, a subsidiary of global genomics leader BGI Group, announced its first early access customer for the MGISEQ-T7, announced an MGI global sequencer user program, and updated numbers for the product install base. The company released a statement summarizing the presentation.

    Jan 11, 2019

  • The Scope Of Scrutiny

    Bio-IT World Contributed Commentary | As biotechnology, pharmaceutical, and medical device companies pursue treatment innovations to improve patient outcomes across diagnoses, many miss a significant step that has been fundamental in financial services and insurance: financial compliance risk management.

    Jan 11, 2019

  • 23andMe Will Add Weight-Loss Advice To Its DNA-Testing Services

    Bloomberg | Consumer DNA-testing giant 23andMe plans to add new wellness offerings it hopes will help its customers shed a few pounds, but some genetics experts say the jury is still out on the science behind the products.

    Jan 9, 2019

  • Igneous Brings Structure To Unstructured Data With As-A-Service Solution

    Bio-IT World | Igneous is offering its cloud-native solution to data-centric organizations in order to both monitor large amounts of data and prevent silos within the clinical research space.

    Jan 9, 2019

  • Eli Lilly Makes An $8B Cancer Genetics Bet With Loxo Acquisition

    Xconomy | Eli Lilly is set to acquire Loxo Oncology for approximately $8 billion---a deal that brings to the Indianapolis pharmaceutical giant a class of drugs that treat cancers with particular genetic signatures.

    Jan 7, 2019

  • 10x Genomics Announces $35m Funding

    Bio-IT World News Brief | On day one of the JP Morgan Healthcare Conference, 10x Genomics announces $35 million in funding as an extension of its Series D financing.

    Jan 7, 2019